Evaluation of the Effects of Baricitinib and Ruxolitinib in Acute Respiratory Distress Syndrome (ARDS) Patients: A Meta-Analysis Study

Evaluation of the Effects of Baricitinib and Ruxolitinib in Acute Respiratory Distress Syndrome (ARDS) Patients: A Meta-Analysis Study

Background: Acute respiratory distress syndrome (ARDS) is a severe lung disease with a high rate of morbidity and mortality. Baricitinib and Ruxolitinib, known as Janus kinase (JAK) inhibitors, have shown promise in mitigating the inflammatory response associated with ARDS. This study aims to system...

Full description

Saved in:
Bibliographic Details
Main Authors: Mehdi Nurmohammad Ahari, Ata Mahmoodpoor, Hassan Soleimanpour, Hamed Valizadeh, Shadi Ziaie, Hadi Hamishehkar
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2025-04-01
Series:Pharmaceutical Sciences
Subjects:
ards
baricitinib
mortality rate
ruxolitinib
Online Access:https://ps.tbzmed.ac.ir/PDF/ps-31-127.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://ps.tbzmed.ac.ir/PDF/ps-31-127.pdf

Similar Items